How PM Modi combined varjish and virasat, legacy and lifestyle through Yoga Day
Since 2015, Prime Minister Narendra Modi has elevated Yoga into a global phenomenon, merging legacy with contemporary lifestyle. By promoting Yoga as a holistic practice that blends physical postures (asanas), breath control (pranayama) and meditation, he has made it relevant to today's fast-paced world.
Events at iconic Indian sites like Rani Ki Vav and Konark's Sun Temple during connect Yoga to our civilizational heritage and its adoption in gyms, corporate offices and colleges, reflect its seamless integration into modern lifestyles. PM Modi's vision has ensured Yoga remains a living tradition and not a relic.
A decade ago PM Modi proposed June 21 as the International Day of Yoga during his inaugural UN General Assembly speech. Within an unprecedented 90 days the resolution garnered support from 177 countries, setting a record for the fastest UN consensus. This diplomatic triumph was not just a win for India but a recognition of Yoga as a secular, inclusive practice. PM Modi's persistent advocacy through international forums and bilateral engagements ensured Yoga's official recognition and millions now participate in Yoga Day celebrations, from New York's Times Square to Tokyo's public squares.
Since then, Yoga has evolved into a bigger worldwide phenomenon. Its appeal lies in its simplicity and adaptability, requiring only a mat and of course mindfulness. Indian embassies and cultural missions have fueled this global enthusiasm through 'Yoga diplomacy' organising events, workshops and festivals. Social media has amplified its reach with influencers, celebrities and everyday practitioners sharing Yoga's benefits. Yoga's universal language of wellness has made it a truly global movement.
On one hand, Yoga embodies India's virasat (heritage) while redefining varzish (fitness). By hosting Yoga sessions at 100 iconic tourist spots and 50 cultural heritage sites, India is underscoring Yoga's deep roots in our civilizational ethos. These sites are not mere backdrops but symbols of continuity, linking ancient wisdom to modern practice. Unlike Western fitness regimes focused on competition, Yoga offers an inclusive, collaborative approach to fitness, aiming for harmony between body, mind and environment.
In a sense, it is also our message to the world – we need less of divided camps and fighting and more of uniting – from Ukraine to Russia, from Israel to Iran. We need a situation of collaboration with environment not one of conflict.
Yoga's greatest strength is its inclusivity, transcending barriers of religion, culture, and ideology. Rooted in Indian philosophy, it requires no faith or ritual- only awareness and discipline. Christians in California to Muslims in Abu Dhabi to Buddhists in Tokyo
and atheists in Beijing – all practice Yoga and are united by its universal appeal. In a polarised world, Yoga serves as an apolitical oasis fostering unity through shared breath.
This message of Yog or union is what makes it India's most potent expression of soft power, quietly shaping global perceptions and narratives without force. Unlike traditional diplomacy, Yoga builds bridges through serenity not cynical strategy. Indian missions worldwide host Yoga programs, while Indian Yoga teachers are celebrated globally.
This subtle cultural influence strengthens India's global presence fostering goodwill and mutual respect by offering a philosophy of peace and wellness. Yoga truly positions India as a beacon of harmony in a world grappling with division and conflict. It strengthens our advocacy of Buddh over Yuddh!
Yoga has also revolutionised fitness by offering a low-cost, low-injury and high-impact alternative to conventional workouts. Its emphasis on mindfulness and flexibility suits all ages and all body types, challenging the aggressive, vanity-driven pumping iron culture. Integrated into corporate wellness programs, schools (via NEP 2020) and public health initiatives like Ayushman Bharat, Yoga promotes preventive healthcare and reduces non-communicable diseases too.
Yoga industry has also sparked huge economic growth. Globally, it's a US 130 billion dollar market with India's wellness economy projected to hit US 70 billion dollars by 2026. The Ministry of AYUSH's Yoga Certification Board has professionalised training, creating jobs for thousands, especially in tier-2 and tier-3 cities as certified trainers, retreat facilitators and wellness consultants. Digital Startups are merging technology with tradition, offering AI-driven posture correction and virtual classes, further boosting the Yoga economy.
Under PM Modi's leadership, Yoga has now transcended its ancient origins to become a global lifestyle, uniting heritage and fitness, tradition and innovation, Vyayaam and Virasat. Its official recognition by the UN, its widespread global adoption and its economic impact highlight India's cultural influence.
As a soft power, Yoga builds bridges where muscular politics falter and its inclusive nature unites diverse communities. Yoga is not just India's past—it's shaping a healthier, harmonious future for the world, with Bharat truly in the leading pose.
Facebook Twitter Linkedin Email Disclaimer
Views expressed above are the author's own.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
an hour ago
- News18
'Takes Skill To Be Still': Shubhanshu Shukla Shares Throwback Video Of Him Floating In Space
Shukla took to Instagram to share a video of his days at the space station, where he was seen trying to stay absolutely still in microgravity. Days after returning from a historic mission on the International Space Station, Indian Air Force pilot Group Captain Shubhanshu Shukla shared a video of his days at the space station, where he was seen trying to stay absolutely still in microgravity. Shukla, who was among the four crew members who flew aboard SpaceX Dragon on June 25, shared a video on Instagram of their first few days of the Axiom-4 mission, where he described the challenge of remaining immobile in space. 'From the time we reached ISS we were quite busy in chasing the timeline and completing our tasks and experiments. It is a bit challenging initially as you are learning to move in microgravity and also getting to know the station," he said in the caption. Shukla said the video was from a few days into the mission, when he had managed better control over his movements in space, while sitting in a cross-legged position. 'What I wanted to do was to be just still but clearly failed. Any small disturbance can move your body in space and it takes skill to be completely still," he said. 'Kind of like our minds in this fast moving world. Take some time to be still today. It is important to sometimes slow down to be fast. Apparently being still is a challenge with or without gravity," he added. Shukla returned safely to Earth as SpaceX's Dragon capsule, Grace, on July 15, after it made the splashdown into the Pacific Ocean, off the coast of San Diego in Southern California. ISRO confirmed that the initial health assessments indicated that Shukla was in stable condition and reported no immediate health concerns. He was flown to Houston, where he also met his family members, including his wife and child. He also met fellow Gaganyaan astronaut-designate Group Captain Prasanth Balakrishnan Nair, who trained alongside Shukla for the Axiom Mission-4 and remained on standby, and other ISRO team members. The space agency confirmed that Shukla has begun a week-long rehabilitation programme under the supervision of Axiom Space's flight surgeon and ISRO's flight surgeon to mitigate any adverse effects of microgravity. This includes a series of medical checks, especially cardiovascular assessments, musculoskeletal tests, and psychological debriefs. Launched on June 25, the mission marked the first time an Indian entered the International Space Station and performed experiments in microgravity. Shukla also brought along with him the results of the seven experiments, which were developed by Indian research institutions under the Human Space Flight Centre's coordination. First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
India.com
an hour ago
- India.com
Good news! Now you can get insurance for low price, get Rs 2 lakh cover for only Rs 20 in this govt scheme, name is….
Good news! Now you can get insurance for low price, get Rs 2 lakh cover for only Rs 20 in this govt scheme, name is…. Get Rs 2 lakh insurance for just a cost of two tea cups. Know about Pradhan Mantri Suraksha Bima Yojana here. By Joy Pillai Edited by Joy Pillai Advertisement Good news! Now you can get insurance for low price, get Rs 2 lakh cover for only Rs 20 in this govt scheme, name is.... Pradhan Mantri Suraksha Bima Yojana: Many people have a habit of drinking tea and smoking cigarettes. This habit affects health and, in the long run, causes serious diseases. But what if we tell you that you can buy insurance worth Rs 2 lakh just by skipping two cups of tea or a cigarette? Today, we are telling you about an insurance scheme that provides financial security at a very low premium. No, it is not a fraud scheme, and there are no hidden charges either, because the scheme is run by the Government of India. The name of this scheme is Pradhan Mantri Suraksha Bima Yojana (PMSBY). Let's know more about the scheme. What Is Pradhan Mantri Suraksha Bima Yojana? Pradhan Mantri Suraksha Bima Yojana is basically an accident insurance scheme which offers accidental death and disability cover on account of an accident. The aim of the scheme is to provide financial strength to economically weaker families. The premium under PMSBY is only Rs. 20 per year. Under this scheme, you can also deposit a premium of Rs. 2 every month. Under this scheme, this amount is deducted from your Aadhaar linked bank account every year. Advertisement === Key Features Of PMSBY If the insured person becomes completely disabled in an accident, then he is eligible to get Rs 2 lakh. In case of a partial accident, Rs 1 lakh is given under the scheme. Advertisement === The insurance can be renewed every year. If the policyholder dies, then this money is given to the family. Who Can Avail The Benefit? People between the ages of 18 to 70 can avail themselves of the benefits of the scheme. Notably, this policy ends automatically on completion of the age of 70 years. Only Indian citizens are eligible for the security insurance scheme. The applicant must have an active bank account in any bank, which is linked to Aadhaar. If your bank account is closed then this policy will also end. The policy cover period is between 1st June to 31st May. What Is The Process Of Applying? To apply for this insurance program, apply at your bank. The bank will provide an application form which, once completed and submitted with the required documents, will initiate the process.
&w=3840&q=100)
Business Standard
2 hours ago
- Business Standard
CDMOs gear up for peptide boom amid rising demand for weight-loss drugs
As global demand for next-generation weight-loss and diabetes therapeutics surges, India's contract development and manufacturing organisations (CDMOs) are strategically positioning themselves to capture a bigger share of the peptide market, particularly in anticipation of key patent expiries such as that of semaglutide—a blockbuster GLP-1 receptor agonist. India is poised to play a critical role in the global manufacturing of GLP-1 drugs, driven by soaring demand for therapies like semaglutide and tirzepatide. The GLP-1 market is projected to exceed $150 billion by 2030. India's peptide CDMO market, currently estimated at around $80 million, is expected to grow at a CAGR of 14 per cent until 2030. Though the country currently accounts for just 3 per cent of the global peptide CDMO space—valued at $190 billion—the growth momentum is unmistakable, according to Nilaya Varma, Co-founder and Group CEO of Primus Partners. Top Indian players in the space include Glenmark, Cipla, Divi's Laboratories, Themis Medicare, Peptomer Therapeutics, Syngene International, and Sai Life Sciences. Semaglutide patent expiry fuels strategic activity Semaglutide, the active ingredient in drugs such as Ozempic and Wegovy, is owned and produced by Novo Nordisk and is set to go off-patent in India in March 2026. Leading pharmaceutical companies, including Dr Reddy's Laboratories, Sun Pharma, Cipla, Mankind Pharma, Natco Pharma, Lupin, and Biocon, are preparing to launch drugs in this category. These companies are investing in R&D, manufacturing capacity, and collaborations to compete in this rapidly growing market. Anthem Biosciences is experiencing a surge in inquiries for peptide active pharmaceutical ingredients (APIs), including those related to weight loss. 'Semaglutide can be produced through total synthesis or biosynthetic routes. Very few companies in India can manage biosynthetic production—and we are one of them,' said Ganesh Sambasivam, Promoter and Chief Scientific Officer at Anthem. While he declined to confirm whether semaglutide is in active production at Anthem, he hinted that it may be among the peptides currently in development. Syngene highlights technical edge in peptide trials Jayashree Aiyar, Chief Scientific Officer at Syngene International, sees opportunities not just in manufacturing, but also in preclinical and clinical development. 'We've already supported preclinical studies on semaglutide and recently helped a global pharma company with a bioequivalence study using pre-filled pens,' Aiyar said. These studies included developing and validating sensitive LC-MS/MS methods to measure semaglutide plasma levels—a significant technical challenge for peptides. Syngene's case study on semaglutide demonstrates the rigorous planning and execution required for clinical bioequivalence trials involving peptides. With gastrointestinal side effects common among test subjects, the company had to implement robust risk management and continuous patient support mechanisms. On the analytical front, it overcame complex challenges like autosampler carryover and low detection limits through custom-developed chromatography and mass spectrometry protocols. 'While we are not currently manufacturing GLP-1 APIs, we are well-equipped with peptide scale-up and fill–finish capabilities. We continue to invest in technologies to meet future market needs,' Aiyar added. Production and compliance challenges persist However, peptide manufacturing comes with its own set of challenges. 'There are production hurdles involving the availability of protected amino acids, coupling reagents, and advanced purification protocols, particularly for bulk APIs,' Varma noted. These challenges, combined with high utility costs and stringent environmental controls, add pressure to meet international compliance standards. Schemes such as the 2024 Production Linked Incentive (PLI) and Greenfield Bulk Drug Park initiatives are expected to ease some of these bottlenecks. While some CDMOs are already entrenched in the space, others are evaluating the landscape. Kashmik Formulations, for instance, is not currently working on semaglutide or related APIs, nor has it received client inquiries. However, the company sees the patent expiry of semaglutide as a potential inflection point. 'We're open to collaborations with larger players who can provide validated processes,' the company said in a statement. Diabetes burden drives urgency for scalable solutions The spike in demand is closely linked to a global epidemic of lifestyle diseases. Arushi Jain, Director at Akums Drugs & Pharmaceuticals, underscores this urgency. 'Over 100 million Indians are living with diabetes, underlining the need for scalable therapeutic solutions that address root causes such as obesity.' Akums is actively tracking developments in weight-loss APIs. As patents for semaglutide and similar molecules expire, Indian CDMOs are gearing up for a new wave of growth. Equipped with scientific expertise, evolving infrastructure, and an appetite for collaboration, the Indian peptide manufacturing ecosystem is emerging as a vital player in the global fight against obesity and metabolic diseases.
